Dr. Katherine Van Loon on Monitoring Recurrences in Gastrointestinal Cancers
Katherine Van Loon, MD, discusses identifying recurrences in gastrointestinal cancers at a point where patients can receive further therapy.
Katherine Van Loon, MD, gastrointestinal cancer specialist, University of California, San Francisco, discusses identifying recurrences in gastrointestinal cancers at a point where patients can receive further therapy.
Van Loon says that oncologists need further research into how often and for how long patients with gastrointestinal cancers should be monitored. She adds that current guidelines state that patients should be followed up on for approximately five years, though recurrences have happened as far out as 10 years.
Fedratinib Shows Promise in Chronic Neutrophilic Leukemia and MDS/MPN
January 20th 2025In an interview, Andrew Kuykendall, MD, discussed fedratinib’s potential as an effective option for patients with myelodysplastic syndrome/myeloproliferative neoplasms and chronic neutrophilic leukemia.
Read More
